CLRB Cellectar Biosciences Inc

Cellectar Biosciences Inc is a biopharmaceutical company. It is engaged in developing compounds for treatment and imaging of cancer. Its portfolio consists of PET imaging agents, optical imaging agents, and therapeutic agents.

$1.32
As of 05/10/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  12/31/2012
Outstanding shares:  52,726,278
Average volume:  421,383
Market cap:   $71,707,738
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    15117F500
ISIN:        US15117F5008
Sedol:      BFMLHQ0
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   1.12
PS ratio:   0.00
Return on equity:   -27.55%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy